About

About TissueLabs TissueLabs is a biotech company on a mission to make lab-grown organs a reality — starting with the most ambitious goal in regenerative medicine: creating a transplantable bioartificial heart. Our path to this breakthrough is guided by a clear, step-by-step strategy grounded in technological innovation and practical execution. We began by developing a comprehensive biofabrication platform, combining state-of-the-art 3D bioprinting systems with proprietary biomaterials. This platform already empowers researchers to produce 15 different types of human tissue with unmatched precision and consistency. Today, it's trusted by over 250 institutions in more than 30 countries, making it one of the most widely adopted solutions in the field. The next step is to leverage our own platform to create engineered cardiac tissues for pharmaceutical applications. These models will not only generate recurring revenue but also provide critical technical expertise and validation for the development of clinical-grade, implantable tissues. From there, we’ll advance to clinical solutions, starting with bioprinted blood vessels and heart valves. These early clinical applications will set the stage for our ultimate goal: a fully functional, transplantable bioartificial heart. At every stage, TissueLabs is laying the groundwork for a future where regenerative medicine replaces the need for donor organs — turning today’s challenges into tomorrow’s cures.